NHS removes trans guidance claim that puberty blockers are ‘fully reversible,’ adds list of risks

By The Christian Post

NHS workers from the Lesbian, Gay, Bisexual and Transgender community take part in the annual Pride Parade in London on July 6, 2019. | NIKLAS HALLE'N/AFP via Getty Images

The National Health Service in England has updated its policy on puberty blockers by removing the claim that the experimental drugs prescribed to transgender-identifying youth are "fully reversible." It now says it's unknown what the short-term and long-term effects will be on a person's bones, physical body and mental health. 

The use of synthetic hormones to block the puberty processes of children experiencing gender dysphoria has faced increased scrutiny in recent years. And the changes made to the guidance come after a lawsuit was filed against the nation's sole gender clinic, the Tavistock and Portman National Health Service Trust in London, where an individual who underwent these experimental treatments says they caused irreparably harm to their body.

The former NHS guidelines previously stated that puberty blockers were reversible:

Source:The Christian Post